Syra Health Corp (SYRA) Stock Price & Analysis

Syra Health Corp (SYRA) fell 9.26% to USD 0.49 as of June 10, 2026 at 12:38 UTC, according to Nexqual real-time market data.

SYRA last closed at USD 0.54; the session ranged USD 0.43–0.5 on volume of 18,949 shares. Market capitalization is $6.95M, with a 52-week range of USD 0.05–0.7 (OQB). Source: Nexqual, June 10, 2026 at 12:38 UTC.

Key Statistics (as of June 10, 2026 at 12:38 UTC)

PriceUSD 0.49
Change▼ 9.26% (down)
Previous CloseUSD 0.54
OpenUSD 0.45
Day RangeUSD 0.43 – 0.5
52-Week RangeUSD 0.05 – 0.7
Volume18,949 shares
Market Cap$6.95M
ExchangeOQB

Technical Analysis (SYRA)

Nexqual's technical model rates SYRA "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 12:38 UTC.

Overall SignalSTRONG BUY
RSI (14)59.3 (neutral)
vs SMA50Above (USD 0.43)
MACD0.03 (positive)

Analyst Ratings (SYRA)

Wall Street analysts rate SYRA "None", per Nexqual as of June 10, 2026 at 12:38 UTC.

Consensus RatingNone

Earnings (SYRA)

Source: Nexqual, June 10, 2026 at 12:38 UTC.

Financials & Fundamentals (SYRA)

Total Revenue$7.64M
Revenue Growth (YoY)+22.40%
Gross Margin+37.55%
Operating Margin+8.40%
Profit Margin-2.40%
ROE-7.60%
Debt / Equity3.09
Current Ratio2.48
Total Cash$2.92M
Total Debt$73,086
Free Cash Flow$470,013

Source: Nexqual, June 10, 2026 at 12:38 UTC.

Financial Health Score (SYRA)

Nexqual rates Syra Health Corp's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 12:38 UTC.

GrowthCritical — Revenue -100% YoY (annual), sharp decline
ProfitabilityWeak — Pre-revenue or very early stage
Balance SheetStrong — $3M cash, no debt
Cash FlowSolid — Operating cash flow $756K
EfficiencyCritical — ROE -8%, ROA -3.9%

Ownership (SYRA)

Insider Ownership+50.83%
Institutional Ownership+0.00%
Shares Outstanding13.84M
Float6.81M
Short % of Float+4.10%

Source: Nexqual, June 10, 2026 at 12:38 UTC.

Leadership (SYRA)

Syra Health Corp is led by Gregory R. Alexander (age 56), Chief Executive Officer, per Nexqual as of June 10, 2026 at 12:38 UTC.

Chief Executive OfficerGregory R. Alexander (age 56)
CFO, COO & DirectorPriya Prasad (age 47)
IR/PR, Communications & Marketing DirectorChristine Drury
Senior Executive Director of People & OperationsJacop Lucas

Major Backers & Investors (SYRA)

Notable institutional backers of Syra Health Corp include Jane Street Group, LLC, Xtx Topco Ltd, according to Nexqual as of June 10, 2026 at 12:38 UTC.

Active Investors

InvestorStake
Jane Street Group, LLC1.32%
Xtx Topco Ltd0.2%

Index Funds (Passive)

FundStake
Vanguard Group0.3%

Source: Nexqual, June 10, 2026 at 12:38 UTC.

From Syra Health Corp's Latest SEC 10-K Filing (filed 2026-03-12)

Key Strengths & Strategy (as disclosed to the SEC)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
HKITHitek Global Inc.USD 0.27▼ 2.85%
MGIHMillennium Group International USD 1.69▲ 19.86%
CCTGCCSC Technology International HUSD 1.78▲ 282.8%
OMHOhmyhome LimitedUSD 0.61▼ 12.7%
ARBBARB IOT Group LimitedUSD 5.67▲ 0.98%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 12:38 UTC. This page is informational and not investment advice.